Home » Newsletters » BioWorld

BioWorld

Jan. 31, 1994

View Archived Issues

TELIOS LAYS OFF 20 WORKERS

COLD SORES IMPLICATED IN AIDS TRANSMISSION BY ORAL SEX

SHAMAN BEGINS PROVIR TRIAL IN CHILDREN

FDA OKS NEW COLLAGRAFT STRIP

DNAP COMPLETES FRESHWORLD ACQUISITION

FDA PANEL REVIEWS SKB'S HEPATITIS A VACCINE

NIH TO LICENSE HEAT SHOCK MOLECULE

NEXAGEN IPO RAISES $23M

APHTON DRUG NEUTRALIZES COLON CANCER HORMONE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...